Risks and Side Effects
Long-term effects of DPP-4 inhibitors on mortality and morbidity are so far inconclusive, although adverse effects, including nasopharyngitis (the common cold), headache, nausea, hypersensitivity and skin reactions, have been observed in clinical studies. Consistent with this FDA approval of Novartis' DPP-4 inhibitor vildagliptin (Galvus®) was delayed because of skin lesions with blistering observed in nonhuman primate toxicology studies; one year later, Novartis CEO Dan Vasella remained uncertain as to their ability to ever file to market the drug in the United States. Other possible adverse effects, including hypersensitivity reactions and pancreatitis, have been reported. These effects may relate to DPP-4's function in restricting the inflammatory actions of the chemokine CCL11/eotaxin, so that inhibiting DPP-4 might unleash the recruitment of inflammatory cells.
Although one in vitro study found that DPP-4 inhibitors, together with GLP-2, increased proliferation and migration of colon cancer cells, which might encourage cancer cells to metastasize, carcinogenicity has not been confirmed in long-term, preclinical studies of the major DPP-4 inhibitors.
Read more about this topic: Dipeptidyl Peptidase-4 Inhibitors
Famous quotes containing the words risks, side and/or effects:
“The question is whether personal freedom is worth the terrible effort, the never-lifted burden and risks of self-reliance.”
—Rose Wilder Lane (1886–1968)
“The most interesting thing which I heard of, in this township of Hull, was an unfailing spring, whose locality was pointed out to me on the side of a distant hill, as I was panting along the shore, though I did not visit it. Perhaps, if I should go through Rome, it would be some spring on the Capitoline Hill I should remember the longest.”
—Henry David Thoreau (1817–1862)
“The machines that are first invented to perform any particular movement are always the most complex, and succeeding artists generally discover that, with fewer wheels, with fewer principles of motion, than had originally been employed, the same effects may be more easily produced. The first systems, in the same manner, are always the most complex.”
—Adam Smith (1723–1790)